BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 15448727)

  • 1. Kinetics and specificity of guinea pig liver aldehyde oxidase and bovine milk xanthine oxidase towards substituted benzaldehydes.
    Panoutsopoulos GI; Beedham C
    Acta Biochim Pol; 2004; 51(3):649-63. PubMed ID: 15448727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of aldehyde oxidase, xanthine oxidase, and aldehyde dehydrogenase on the oxidation of aromatic aldehydes.
    Panoutsopoulos GI; Kouretas D; Beedham C
    Chem Res Toxicol; 2004 Oct; 17(10):1368-76. PubMed ID: 15487898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate specificity of guinea pig liver aldehyde oxidase and bovine milk xanthine oxidase for methyl- and nitrobenzaldehydes.
    Veskoukis AS; Kouretas D; Panoutsopoulos GI
    Eur J Drug Metab Pharmacokinet; 2006; 31(1):11-6. PubMed ID: 16715777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic oxidation of phthalazine with guinea pig liver aldehyde oxidase and liver slices: inhibition by isovanillin.
    Panoutsopoulos GI; Beedham C
    Acta Biochim Pol; 2004; 51(4):943-51. PubMed ID: 15625566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of isovanillin by aldehyde oxidase, xanthine oxidase, aldehyde dehydrogenase and liver slices.
    Panoutsopoulos GI; Beedham C
    Pharmacology; 2005 Mar; 73(4):199-208. PubMed ID: 15627845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liver.
    Rashidi MR; Smith JA; Clarke SE; Beedham C
    Drug Metab Dispos; 1997 Jul; 25(7):805-13. PubMed ID: 9224775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenylacetaldehyde oxidation by freshly prepared and cryopreserved guinea pig liver slices: the role of aldehyde oxidase.
    Panoutsopoulos GI
    Int J Toxicol; 2005; 24(2):103-9. PubMed ID: 16036769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent inhibition of human liver aldehyde oxidase by raloxifene.
    Obach RS
    Drug Metab Dispos; 2004 Jan; 32(1):89-97. PubMed ID: 14709625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-substituted phthalazines as probes of the substrate-binding site of mammalian molybdenum hydroxylases.
    Beedham C; Bruce SE; Critchley DJ; Rance DJ
    Biochem Pharmacol; 1990 Apr; 39(7):1213-21. PubMed ID: 2322306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human xanthine oxidase changes its substrate specificity to aldehyde oxidase type upon mutation of amino acid residues in the active site: roles of active site residues in binding and activation of purine substrate.
    Yamaguchi Y; Matsumura T; Ichida K; Okamoto K; Nishino T
    J Biochem; 2007 Apr; 141(4):513-24. PubMed ID: 17301077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of flavonoids on molybdenum hydroxylases activity.
    Rashidi MR; Nazemiyeh H
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):133-52. PubMed ID: 20095789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate specificity of human liver aldehyde oxidase toward substituted quinazolines and phthalazines: a comparison with hepatic enzyme from guinea pig, rabbit, and baboon.
    Beedham C; Critchley DJ; Rance DJ
    Arch Biochem Biophys; 1995 Jun; 319(2):481-90. PubMed ID: 7786031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro study of 6-mercaptopurine oxidation catalysed by aldehyde oxidase and xanthine oxidase.
    Rashidi MR; Beedham C; Smith JS; Davaran S
    Drug Metab Pharmacokinet; 2007 Aug; 22(4):299-306. PubMed ID: 17827784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oxidation of azaheterocycles with mammalian liver aldehyde oxidase.
    Stubley C; Stell JG; Mathieson DW
    Xenobiotica; 1979 Aug; 9(8):475-84. PubMed ID: 516790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics and specificity of human liver aldehyde dehydrogenases toward aliphatic, aromatic, and fused polycyclic aldehydes.
    Klyosov AA
    Biochemistry; 1996 Apr; 35(14):4457-67. PubMed ID: 8605195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfoxide reductase activity of liver aldehyde oxidase.
    Tatsumi K; Kitamura S; Yamada H
    Biochim Biophys Acta; 1983 Sep; 747(1-2):86-92. PubMed ID: 6688361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel ring oxidation of 4- or 5-substituted 2H-oxazole to corresponding 2-oxazolone catalyzed by cytosolic aldehyde oxidase.
    Arora VK; Philip T; Huang S; Shu YZ
    Drug Metab Dispos; 2012 Sep; 40(9):1668-76. PubMed ID: 22621803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of density functional calculations to predict the regioselectivity of drugs and molecules metabolized by aldehyde oxidase.
    Torres RA; Korzekwa KR; McMasters DR; Fandozzi CM; Jones JP
    J Med Chem; 2007 Sep; 50(19):4642-7. PubMed ID: 17718551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molybdenum hydroxylase super family shows circadian activity fluctuation in mice liver: emphasis on aldehyde hydroxylase and xanthine oxidase.
    Al-Abbasi FA; Al-Sieni AI
    Pak J Pharm Sci; 2010 Oct; 23(4):359-62. PubMed ID: 20884446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of flavonoids on aldehyde oxidase activity.
    Pirouzpanah S; Hanaee J; Razavieh SV; Rashidi MR
    J Enzyme Inhib Med Chem; 2009 Feb; 24(1):14-21. PubMed ID: 18608746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.